Sfoglia per Autore
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.
2013-01-01 Ruella M; Salmoiraghi S; Risso A; Carobbio A; Buttiglieri S; Spatola T; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A.
Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy.
2013-01-01 Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C.
Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose
2013-01-01 130. Devizzi L; Guidetti A; Seregni E; Passera R; Maccauro M; Magni M; Testi A; Di Nicola M; Tarella C; Matteucci P; Viviani S; Ruella M; Carlo-Stella C; Chiesa C; Cox MC; Bombardieri E; Gianni AM.
Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups.
2013-01-01 Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GE; Luzi L; Alcalay M; Dellino GI; Pelicci PG
Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
2012-01-01 Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C.
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
2012-01-01 Olivieri A; Marchetti M; Lemoli R; Tarella C; Iacone A; Lanza F; Rambaldi A; Bosi A
Preoperative mobilization of bone marrow-derived cells followed by revascularization surgery: early and long-term outcome
2012-01-01 Dato GM; Sansone F; Omedé P; Zingarelli E; Flocco R; Punta G; Parisi F; Forsennati PG; Bardi GL; Del Ponte S; Casabona R; Tarella C
Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int. 2012;2012:326813. Epub 2012 Mar 7
2012-01-01 Marmotti A; Mattia S; Bruzzone M; Buttiglieri S; Risso A; Bonasia DE; Blonna D; Castoldi F; Rossi R; Zanini C; Ercole E; Defabiani E; Tarella C; Peretti GM.
A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept
2012-01-01 C.M. FRONTICELLI BALDELLI; M. RUELLA; S. SCUDERI; M. MONNI; R. PASSERA; P. OMEDE; C. TARELLA
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
2012-01-01 Guidetti A; Carlo-Stella C; Locatelli SL; Malorni W; Pierdominici M; Barbati C; Mortarini R; Devizzi L; Matteucci P; Marchianò A; Lanocita R; Farina L; Dodero A; Tarella C; Di Nicola M; Corradini P; Anichini A; Gianni AM.
Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use
2012-01-01 Mareschi K; Rustichelli D; Calabrese R; Gunetti M; Sanavio F; Castiglia S; Risso A; Ferrero I; Tarella C; Fagioli F.
Too soon, too much
2011-01-01 Chiò A; Tarella C
Primary duodenal follicular lymphoma: 6-years complete remission after combined radio-immunotherapy
2011-01-01 Franco P; Filippi AR; Ciammella P; Botticella A; Namysl-Kaletka A; De Crescenzo A; Tarella C; Ricardi U.
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
2011-01-01 Guidetti A; Carlo-Stella C; Ruella M; Miceli R; Devizzi L; Locatelli SL; Giacomini A; Testi A; Buttiglieri S; Risso A; Mariani L; Di Nicola M; Passera R; Tarella C; Gianni AM
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma
2011-01-01 Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A
The aging effect of chemotherapy on cultured human mesenchymal stem cells
2011-01-01 Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study
2011-01-01 Chiò A, Mora G, Bella VL, Caponnetto C, Mancardi G, Sabatelli M, Siciliano G, Silani V, Corbo M, Moglia C, Calvo A, Mutani R, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Bondesan P, Garbelli S, Mantovani S, Bendotti C, Tarella C; and the STEMALS Study Group
Lymphomatous renal involvement
2010-01-01 Besso L; Quercia AD; Daidola G; Burdese M; Colla L; Basso E; Karvela E; Marcuccio C; Tarella C; Segoloni GP.
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status
2010-01-01 Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C.
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
2010-01-01 Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A; STEMALS Study Group
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy. | 2013 | Ruella M; Salmoiraghi S; Risso A; Carobbio A; Buttiglieri S; Spatola T; Sivera P; Ricca I; Barbui T; Tarella C; Rambaldi A. | |
| Bone marrow-derived cell mobilization by G-CSF to enhance osseointegration of bone substitute in high tibial osteotomy. | 2013 | Marmotti A; Castoldi F; Rossi R; Marenco S; Risso A; Ruella M; Tron A; Borrè A; Blonna D; Tarella C. | |
| Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose | 2013 | 130. Devizzi L; Guidetti A; Seregni E; Passera R; Maccauro M; Magni M; Testi A; Di Nicola M; Tarella C; Matteucci P; Viviani S; Ruella M; Carlo-Stella C; Chiesa C; Cox MC; Bombardieri E; Gianni AM. | |
| Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups. | 2013 | Riva L; Ronchini C; Bodini M; Lo-Coco F; Lavorgna S; Ottone T; Martinelli G; Iacobucci I; Tarella C; Cignetti A; Volorio S; Bernard L; Russo A; Melloni GE; Luzi L; Alcalay M; Dellino GI; Pelicci PG | |
| Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report. | 2012 | Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C. | |
| Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo | 2012 | Olivieri A; Marchetti M; Lemoli R; Tarella C; Iacone A; Lanza F; Rambaldi A; Bosi A | |
| Preoperative mobilization of bone marrow-derived cells followed by revascularization surgery: early and long-term outcome | 2012 | Dato GM; Sansone F; Omedé P; Zingarelli E; Flocco R; Punta G; Parisi F; Forsennati PG; Bardi GL; Del Ponte S; Casabona R; Tarella C | |
| Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int. 2012;2012:326813. Epub 2012 Mar 7 | 2012 | Marmotti A; Mattia S; Bruzzone M; Buttiglieri S; Risso A; Bonasia DE; Blonna D; Castoldi F; Rossi R; Zanini C; Ercole E; Defabiani E; Tarella C; Peretti GM. | |
| A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept | 2012 | C.M. FRONTICELLI BALDELLI; M. RUELLA; S. SCUDERI; M. MONNI; R. PASSERA; P. OMEDE; C. TARELLA | |
| Phase II study of sorafenib in patients with relapsed or refractory lymphoma. | 2012 | Guidetti A; Carlo-Stella C; Locatelli SL; Malorni W; Pierdominici M; Barbati C; Mortarini R; Devizzi L; Matteucci P; Marchianò A; Lanocita R; Farina L; Dodero A; Tarella C; Di Nicola M; Corradini P; Anichini A; Gianni AM. | |
| Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use | 2012 | Mareschi K; Rustichelli D; Calabrese R; Gunetti M; Sanavio F; Castiglia S; Risso A; Ferrero I; Tarella C; Fagioli F. | |
| Too soon, too much | 2011 | Chiò A; Tarella C | |
| Primary duodenal follicular lymphoma: 6-years complete remission after combined radio-immunotherapy | 2011 | Franco P; Filippi AR; Ciammella P; Botticella A; Namysl-Kaletka A; De Crescenzo A; Tarella C; Ricardi U. | |
| Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia | 2011 | Guidetti A; Carlo-Stella C; Ruella M; Miceli R; Devizzi L; Locatelli SL; Giacomini A; Testi A; Buttiglieri S; Risso A; Mariani L; Di Nicola M; Passera R; Tarella C; Gianni AM | |
| Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma | 2011 | Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A | |
| The aging effect of chemotherapy on cultured human mesenchymal stem cells | 2011 | Buttiglieri S; Ruella M; Risso A; Spatola T; Silengo L; Avvedimento EV; Tarella C | |
| Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study | 2011 | Chiò A, Mora G, Bella VL, Caponnetto C, Mancardi G, Sabatelli M, Siciliano G, Silani V, Corbo M, Moglia C, Calvo A, Mutani R, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Bondesan P, Garbelli S, Mantovani S, Bendotti C, Tarella C; and the STEMALS Study Group | |
| Lymphomatous renal involvement | 2010 | Besso L; Quercia AD; Daidola G; Burdese M; Colla L; Basso E; Karvela E; Marcuccio C; Tarella C; Segoloni GP. | |
| Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status | 2010 | Ruella M; Rocci A; Ricca I; Carniti C; Bodoni CL; Ladetto M; Caracciolo D; Boccadoro M; Carlo-Stella C; Corradini P; Tarella C. | |
| Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. | 2010 | Tarella C; Rutella S; Gualandi F; Melazzini M; Scimè R; Petrini M; Moglia C; Ulla M; Omedé P; Bella VL; Corbo M; Silani V; Siciliano G; Mora G; Caponnetto C; Sabatelli M; Chiò A; STEMALS Study Group |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile